- Condition: Gastric Antral Vascular Ectasia
Interventions: Device: Endoscopic Band Ligation; Device: Argon plasma Coagulation (APC) for GAVE
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified May 2012 - Conditions: Probable Migraine; Migraine With Aura; Migraine Without Aura
Interventions: Drug: Ketorolac Tromethamine; Drug: Metoclopramide
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified May 2012 - Condition: Heterotaxy Syndrome
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2012 - Condition: Metastatic Pancreas Cancer
Interventions: Drug: 5FU, leucovorin, oxaliplatin; Drug: Gemcitabine
Sponsors: Alberta Health Services; Alberta Health Services
Not yet recruiting - verified April 2012 - Condition: Influenza
Intervention:
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Conditions: Spinal Cord Injuries; Muscle Spasticity
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Conditions: Intestinal Failure; Short Bowel Syndrome
Interventions: Drug: Glucagon-Like Peptide 2; Drug: Glucagon like peptide-2
Sponsors: Alberta Children's Hospital; Alberta Children's Hospital; Stollery Children's Hospital; The Hospital for Sick Children; Children's & Women's Health Centre of British Columbia
Recruiting - verified April 2012 - Conditions: Aging; Physical Activity
Interventions: Other: Muscle strengthening exercises; Other: Muscle stretching exercise
Sponsors: University of Calgary; University of Calgary; Running Injury Clinic; Alberta Heritage Foundation for Medical Research; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Recruiting - verified April 2012 - Conditions: Supervised Physical Activity Plus Exercise Counseling; Supervised Physical Activity Plus Behavioural Counseling
Intervention: Behavioral: Trying Activity for Kidney Cancer Survivors (TRACKS) Trial
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Chronic Rhinosinusitis
Interventions: Device: NeilMed sinus rinse; Device: Salinex
Sponsors: Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Samuel Lunenfeld Research Institute, Mount Sinai Hospital; NeilMed Pharmaceuticals, donating saline bottles, no direct funding.
Recruiting - verified April 2012 - Condition: Low Back Pain, Mechanical
Intervention: Other: exercise rehabilitation program
Sponsors: Running Injury Clinic; Running Injury Clinic; WCB Alberta; Alberta Health Services
Recruiting - verified March 2012 - Conditions: Liver Failure; Acute Kidney Disease; Multi-organ Failure
Interventions: Device: Continuous renal replacement therapy (CRRT); Procedure: Standard intraoperative support
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Conditions: Chronic Sinusitis; Endoscopic Sinus Surgery; Post-operative Care; Steroids; Drug-eluting Spacer
Interventions: Device: Steroid-eluting middle meatal spacer (Nasopore (TM) spacer impregnated with 1 cc of 40mg/mL triamcinolone liquid); Drug: Post-op Oral Steroids
Sponsors: University of Calgary; University of Calgary
Not yet recruiting - verified March 2012 - Conditions: Colles Fracture; Point of Care Ultrasound; Emergency Ultrasound
Intervention: Device: Point of care ultrasound
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified April 2012 - Conditions: Breast Neoplasms; Lymphedema
Interventions: Behavioral: Night-time compression system garment; Behavioral: Day-time compression sleeve
Sponsors: University of Alberta; University of Alberta; Alberta Health Services; Canadian Breast Cancer Foundation
Recruiting - verified April 2012 - Condition: Nasal Obstruction
Intervention: Device: Septal Stapler
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified February 2012 - Conditions: Diabetes; Stroke; Obesity
Intervention:
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia
Recruiting - verified March 2012 - Condition: Metastasis to Brain of Primary Cancer
Intervention: Radiation: Whole brain external beam radiation with simultaneous in-field boost
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Ontario Institute for Cancer Research
Recruiting - verified February 2012 - Condition: Parkinson Disease
Intervention:
Sponsors: Indiana University; Indiana University; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified February 2012 - Condition: Coronary Artery Disease
Intervention: Procedure: BP Measurements at aorta, radial and femoral locations
Sponsors: University of Alberta; University of Alberta
Recruiting - verified March 2012 - Condition: End Stage Renal Disease
Interventions: Procedure: Standard treatment; Procedure: Two dialyzers
Sponsors: University of Alberta; University of Alberta; University of Calgary
Not yet recruiting - verified February 2012 - Condition: Malocclusion, Angle Class II
Interventions: Device: Brackets plus Forsus springs; Device: Xbow plus full brackets
Sponsors: University of Alberta, Graduate Orthodontic Program; University of Alberta, Graduate Orthodontic Program
Not yet recruiting - verified February 2012 - Condition: Children's Distress During Flu Vaccination
Intervention:
Sponsors: University of Calgary; University of Calgary
Completed - verified February 2012 - Condition: Total Hip Replacement
Interventions: Device: Secure-Fit™ arc-deposited Hydroxylapatite (HA) shell - surface ceramic and an Alumina Bearing Couple (ABC) ceramic insert and Ceramic C-taper head; Device: Secure-Fit™ arc-deposited hydroxylapatite shell, a Crossfire® insert and a Ceramic C-taper head
Sponsors: University of Alberta; University of Alberta; Stryker Canada
Active, not recruiting - verified February 2012 - Condition: Percutaneous Tracheostomy
Intervention: Procedure: Percutaneous tracheostomy
Sponsors: University of Alberta; University of Alberta
Recruiting - verified January 2012 - Conditions: Local Anesthesia; Catheterization
Interventions: Procedure: Catheter placement method; Procedure: Catheter placement method
Sponsors: University of Alberta; University of Alberta
Recruiting - verified January 2012 - Conditions: Local Anesthesia; Analgesia
Interventions: Procedure: Local anesthetic delivery; Procedure: Local anesthetic delivery
Sponsors: University of Alberta; University of Alberta
Recruiting - verified January 2012 - Conditions: Asthma; Education
Intervention: Other: Asthma Transition Program
Sponsors: University of Calgary; University of Calgary
Recruiting - verified January 2012 - Conditions: Spinal Cord Injuries; Muscle Spasticity
Intervention:
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified January 2012 - Condition: Recurrent Acute Tonsillitis
Interventions: Drug: Ketorolac; Drug: Normal Saline
Sponsors: University of Alberta; University of Alberta
Recruiting - verified December 2011 - Condition: Acute Respiratory Distress Syndrome (ARDS)
Interventions: Device: SensorMedics 3100B High Frequency Oscillatory Ventilator; Procedure: Lung Protective Ventilation
Sponsors: Canadian Critical Care Trials Group; Canadian Critical Care Trials Group; Canadian Institutes of Health Research (CIHR); McMaster University; University of Toronto
Recruiting - verified January 2010 - Condition: Cardiac Surgery
Interventions: Other: Liberal transfusion triggers; Other: Restrictive transfusion triggers
Sponsors: St. Michael's Hospital, Toronto; Nadine Shehata; Canadian Institutes of Health Research (CIHR); Health Canada
Recruiting - verified May 2012 - Conditions: Colorectal Cancer; Colorectal Polyps
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified December 2011 - Condition: High-risk Prostate Cancer
Interventions: Radiation: Standard Radiation Treatment; Radiation: Hypofractionated radiation treatment
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified May 2012 - Condition: Malignant Pleural Mesothelioma
Intervention: Drug: PF-03446962
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Conditions: Hypotension; Low Blood Pressure; Prematurity of Fetus
Interventions: Drug: Dopamine hydrochloride; Drug: Dextrose 5%
Sponsors: University College Cork; University College Cork; BrePco Biopharma Limited; Cork University Hospital; Katholieke Universiteit Leuven; Univerzita Karlova v Praze; Centre hospitalier universitaire Sainte-Justine; University College Dublin; Coombe Women and Infants University Hospital; University of Alberta; Royal College of Surgeons, Ireland; GABO:milliarium mbH & Co. KG; National de la Santé et de la Recherche Medicale; University College, London; Clininfo S.A.
Not yet recruiting - verified November 2011 - Condition: Mobility Limitation
Intervention: Other: Sit-to-Stand Activity
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR); CapitalCare Continuing Care; Extendicare; Good Samaritan Society; Shepherd's Care Foundation
Recruiting - verified November 2011 - Conditions: Transtracheal Injection; Fibreoptic Intubation
Interventions: Procedure: Transtracheal injection; Procedure: Transtracheal injection
Sponsors: University of Alberta; University of Alberta
Recruiting - verified December 2011 - Conditions: Mindfulness-Based Stress Reduction (MBSR); Cancer
Interventions: Other: Immediate MBSR; Other: Wait-list Control Group.
Sponsors: Alberta Health Services; Alberta Health Services; Tom Baker Cancer Centre
Recruiting - verified November 2011 - Conditions: Infection; Bone Neoplasms
Intervention: Procedure: Prophylactic Cefazolin Antibiotic Regimen
Sponsors: McMaster University; Michelle Ghert
Not yet recruiting - verified April 2012 - Conditions: Sub-optimal Vitamin D Status; Bone Disease; Diabetic Nephropathy
Intervention: Drug: Vitamin D3
Sponsors: University of Alberta; University of Alberta
Enrolling by invitation - verified November 2011 - Condition: Cardiac Sarcoidosis
Intervention:
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Ontario Ministry of Health and Long Term Care
Not yet recruiting - verified December 2011 - Condition: Diabetic Peripheral Neuropathy
Interventions: Drug: Novolin Toronto insulin; Drug: Normal saline
Sponsors: University of Calgary; University of Calgary
Recruiting - verified November 2011 - Condition: Cancer of the Endometrium
Intervention:
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Not yet recruiting - verified November 2011 - Condition: Carotid Plaque
Intervention: Other: Imaging
Sponsors: University of Western Ontario, Canada; University of Western Ontario, Canada; Canadian Institutes of Health Research (CIHR)
Recruiting - verified October 2011 - Condition: Vasovagal Syncope
Interventions: Drug: midodrine hydrochloride; Drug: matching placebo
Sponsors: University of Calgary; Dr. Bob Sheldon; Vanderbilt University
Recruiting - verified January 2012 - Condition: Chronic Kidney Disease
Interventions: Other: citrate dialysate (CD); Other: acetic-acid based dialysate (AD)
Sponsors: University of Calgary; University of Calgary
Not yet recruiting - verified November 2011 - Condition: End Stage Renal Disease
Interventions: Dietary Supplement: B and C renal vitamin plus zinc, selenium and vitamin E; Dietary Supplement: B and C renal vitamin
Sponsors: University of Alberta; Cello Tonelli; Alberta Health Services
Not yet recruiting - verified November 2011 - Condition: Prostate Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Thyroid Neoplasms
Interventions: Drug: CPERT; Drug: GPERT
Sponsors: Alberta Health Services; Alberta Health Services; Natural Resources, Canada; Edmonton PET Centre
Recruiting - verified April 2012 - Conditions: Colonic Neoplasms; Iron Deficiency Anemia; Diarrhea
Intervention: Device: Olympus ScopeGuide
Sponsors: University of Alberta; Christopher Teshima
Recruiting - verified April 2012 - Condition: Breast Neoplasms
Interventions: Other: Volume of Exercise; Moderate or High Volume; Other: Aerobic Exercise; Other: Aerobic Exercise
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified September 2011 - Condition: Acute Asthma
Interventions: Drug: Inhaled Magnesium Sulfate; Drug: Hypertonic Saline Placebo
Sponsors: The Hospital for Sick Children; The Hospital for Sick Children
Active, not recruiting - verified September 2011 - Condition: End Stage Renal Disease
Intervention:
Sponsors: University of Alberta; University of Alberta; Massachusetts General Hospital
Recruiting - verified May 2012 - Conditions: Syncope; Heart Block; Conduction Disorder of the Heart
Interventions: Procedure: pacemaker; Procedure: implantable loop recorder
Sponsors: University of Calgary; Canadian Institutes of Health Research (CIHR); Vanderbilt University
Recruiting - verified April 2012 - Conditions: Heart Failure; Atrial Fibrillation
Interventions: Procedure: Catheter ablation-based AF rhythm control; Drug: Medication Rate Control
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Bowel Preparation for Colonoscopy
Interventions: Drug: Polyethylene Glycol-Based Lavage; Drug: Pico-Salax (Magnesium Citrate) plus Bisacodyl
Sponsors: University of Calgary; University of Calgary
Recruiting - verified August 2011 - Conditions: Complications Due to Coronary Artery Bypass Graft; Graft Failure
Interventions: Procedure: On-pump CABG; Procedure: Off-pump CABG
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - verified August 2011 - Condition: Pancreas Cancer
Interventions: Drug: gemcitabine; Drug: 5-fluorouracil
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Breast Cancer
Intervention: Drug: Dasatinib
Sponsors: Alberta Health Services; Alberta Health Services
Withdrawn - verified August 2011 - Conditions: Renin Angiotensin System; Human; Renal Hemodynamics
Intervention: Dietary Supplement: Fructose
Sponsors: University of Calgary; University of Calgary
Recruiting - verified July 2011 - Condition: Acute Exacerbation of Chronic Obstructive Airways Disease
Interventions: Procedure: seamless discharge; Procedure: Usual care
Sponsors: Ward of the 21st Century; Ward of the 21st Century; Canadian Institutes of Health Research (CIHR); Alberta Health Services
Not yet recruiting - verified October 2010 - Condition: Prostate Cancer
Interventions: Behavioral: Telephone Implementation Intention; Behavioral: Self-completed implementation intention
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified August 2011 - Condition: Advanced Rare Tumours
Interventions: Drug: Sunitinib; Drug: Temsirolimus
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Apnea
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified December 2011 - Condition: Osteoporosis
Interventions: Other: case management; Other: Multifaceted quality improvement intervention
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified July 2011 - Condition: Acute Myeloid Leukemia
Intervention:
Sponsors: Center for International Blood and Marrow Transplant Research; Center for International Blood and Marrow Transplant Research; Resource for Clinical Investigations in Blood and Marrow Transplantation (RCI-BMT); Pediatric Blood and Marrow Transplant Consortium
Recruiting - verified May 2012 - Condition: Pulmonary Hypertension
Interventions: Drug: Vasopressin infusion; Drug: Vasopressin infusion and epoprostenol inhalation
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2012 - Condition: Gastroesophageal Reflux
Interventions: Device: Bravo; Device: Standard Care
Sponsors: University of Calgary; University of Calgary
Completed - verified May 2011 - Condition: Stroke
Interventions: Biological: rfVIIa; Other: Standard saline solution
Sponsors: Sunnybrook Health Sciences Centre; Dr. David Gladstone; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Atherosclerosis
Intervention:
Sponsors: Canadian Atherosclerosis Imaging Network; Canadian Atherosclerosis Imaging Network; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Conditions: Disease Due to BK Polyomavirus; Kidney Transplant Infection
Intervention: Drug: Levofloxacin
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR); St. Paul's Hospital, Canada; Vancouver General Hospital; University of Alberta; University of Manitoba; University Health Network, Toronto; St. Michael's Hospital, Toronto; St. Joseph's Healthcare Hamilton; London Health Sciences Centre; McGill University Health Center; Dalhousie University
Recruiting - verified March 2012 - Condition: Small Cell Lung Cancer
Intervention: Radiation: Adaptive Radiation
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Sexual Assault
Interventions: Behavioral: Enhanced AAA Sexual Assault Resistance Education; Behavioral: Brochure
Sponsors: University of Windsor; University of Windsor; Canadian Institutes of Health Research (CIHR)
Recruiting - verified September 2011 - Conditions: Depression; Depressive Symptoms; Type 2 Diabetes
Interventions: Other: TeamCare Depression Intervention; Other: Usual diabetes and depression care
Sponsors: The Alliance for Canadian Health Outcomes Research in Diabetes; The Alliance for Canadian Health Outcomes Research in Diabetes; Alberta Health & Wellness; Canadian Institutes of Health Research (CIHR)
Enrolling by invitation - verified February 2012 - Condition: Patellofemoral Pain Syndrome
Intervention: Device: Knee abduction moment-reducing footwear
Sponsors: University of Calgary; University of Calgary; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified October 2011 - Condition: Influenza
Intervention:
Sponsors: Dalhousie University; Dalhousie University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Depression
Interventions: Behavioral: Telephone-supported self-help and GP treatment as usual; Behavioral: Unsupported self-help and GP treatment as usual; Other: General practitioner treatment as usual
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Canadian Mental Health Association
Recruiting - verified May 2012 - Conditions: Relapsed/Refractory AML; Relapsed/Refractory ALL; Secondary AML/MDS; Acute Leukemia of Ambiguous Lineage; AML; ALL
Intervention: Drug: Plerixafor Dose Escalation
Sponsors: Emory University; Emory University; Children's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics Investigation Consortium
Recruiting - verified January 2012 - Condition: Diabetes Mellitus, Type 2
Intervention: Other: eHealth education
Sponsors: Pacaud, Danièle, M.D.; Dr. Danièle Pacaud; The Lawson Foundation
Completed - verified May 2012 - Condition: Mental Health Wellness 1
Interventions: Other: mindfulness-based stress reduction program; Other: Usual care
Sponsors: University of Alberta; University of Alberta; CASA: Child, Adolescent and Family Mental Health
Recruiting - verified September 2011 - Condition: Congenital Heart Defects
Interventions: Behavioral: Clinic-based Educational Intervention; Other: Usual Care
Sponsors: University of Alberta; University of Alberta; Women and Children's Health Research Institute, Canada; Stollery Children's Hospital Foundation
Recruiting - verified January 2012 - Condition: Obstetric Labor, Premature
Interventions: Drug: Vaginal progesterone; Drug: Placebo
Sponsors: University of Calgary; University of Calgary; Calgary Health Region Perinatal Research Fund
Recruiting - verified February 2012 - Conditions: Obstructive Sleep Apnea; Hypertension; Cardiovascular Diseases; Stroke
Interventions: Other: Intermittent hypoxia; Drug: Indomethacin; Drug: Celecoxib; Drug: Placebo
Sponsors: University of Calgary; University of Calgary
Completed - verified December 2011 - Conditions: Venous Thromboembolism; Postpartum
Interventions: Drug: Dalteparin Sodium; Drug: 0.9% Bacteriostatic Sodium Chloride
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Conditions: Neurogenic Bladder; Spina Bifida
Intervention: Device: Intermittent catheterization
Sponsors: University of Alberta; University of Alberta
Recruiting - verified December 2011 - Conditions: Nutrition Assessment; Obesity
Intervention: Behavioral: Portion Size Measurement Aids (PSMAs)
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Conditions: Obesity; Child
Interventions: Behavioral: Cognitive Behavioural Therapy (CBT); Behavioral: Psycho-Education Program (PEP)
Sponsors: University of Alberta; University of Alberta; Alberta Health Services; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Influenza Infection in Transplant Patients
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Bone Metastases
Interventions: Drug: Dexamethasone; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified March 2012 - Condition: Hyperaldosteronism
Intervention:
Sponsors: University Hospital Padova; University Hospital Padova
Completed - verified December 2011 - Conditions: Acute Kidney Injury; Abdominal Aortic Aneurysm
Interventions: Drug: curcumin; Other: placebo
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Breast Cancer
Intervention: Device: MRS
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Renal Calculi (Kidney Stones)
Intervention: Procedure: ESWL: Extraporeal Shock Wave Lithotripsy Intervention
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Benign Bile Duct Strictures
Interventions: Device: Fully covered Metallic Stent; Device: Plastic Stent
Sponsors: Indiana University; Indiana University; American Society for Gastrointestinal Endoscopy
Recruiting - verified April 2012 - Condition: Hypoplastic Left Heart Syndrome
Intervention: Device: Peritoneal dialysis
Sponsors: University of Alberta; University of Alberta; Women and Children's Health Research Institute, Canada
Recruiting - verified May 2012 - Condition: Cardiac Disease
Interventions: Drug: Atenolol; Drug: Telmisartan; Drug: Atenolol Placebo; Drug: Telmisartan Placebo
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation; Population Health Research Institute
Recruiting - verified March 2012 - Condition: Gestational Hypertension
Interventions: Procedure: Intervention is blood pressure management approach; Procedure: Intervention is blood pressure management approach.
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
Recruiting - verified December 2011 - Conditions: Leukemia; Solid Tumours
Intervention: Drug: SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified April 2012 - Conditions: Stroke; Cerebral Palsy
Interventions: Procedure: Repetitive Transcranial Magnetic Stimulation (rTMS); Procedure: Constraint-induced movement therapy (CIMT)
Sponsors: University of Calgary; University of Calgary; Heart and Stroke Foundation of Canada; University of Alberta
Recruiting - verified September 2011 - Condition: Fever
Interventions: Other: Aggressive Fever Treatment; Other: Permissive Fever Treatment
Sponsors: University of Calgary; University of Calgary; Canadian Intensive Care Foundation
Completed - verified February 2012 - Condition: Adverse Drug Events
Intervention: Behavioral: Medication Reconciliation
Sponsors: Westview Physician Collaborative; Westview Physician Collaborative
Active, not recruiting - verified February 2012 - Condition: Brain Metastases
Intervention: Device: Frameless Stereotactic Radiosurgery with radiation mask
Sponsors: Alberta Health Services; Alberta Health Services; Tom Baker Cancer Centre
Recruiting - verified August 2011 - Conditions: Neoplasms, Colorectal; Colorectal Cancer; Colorectal Carcinoma
Intervention: Other: (supplement) Calcium and Magnesium
Sponsors: Alberta Health Services; Alberta Health Services
Not yet recruiting - verified April 2012 - Condition: Melanoma
Interventions: Drug: rIL-21; Drug: Dacarbazine
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Acute Coronary Syndrome; ST Elevation Myocardial Infarction; Percutaneous Coronary Intervention
Intervention: Procedure: Percutaneous Coronary Intervention with or without manual aspiration thrombectomy
Sponsors: Population Health Research Institute; Population Health Research Institute
Recruiting - verified March 2012 - Condition: Transplant
Intervention:
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified July 2011 - Condition: Bariatric Surgery
Intervention: Drug: Azithromycin
Sponsors: University of Alberta; University of Alberta
Completed - verified July 2011 - Condition: Morbid Obesity
Intervention:
Sponsors: University of Alberta; University of Alberta; Alberta Health Services
Completed - verified December 2011 - Condition: Alcohol Consumption
Interventions: Behavioral: Computer-based Personalized Assessment Feedback; Behavioral: Computer-based sham
Sponsors: University of Alberta; University of Alberta; Norlien Foundation; Women and Children's Health Research Institute, Canada
Recruiting - verified April 2012 - Condition: Multiple Myeloma
Intervention: Drug: AT9283
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Influenza Vaccine
Intervention: Biological: Influenza vaccine: Vaxigrip or Fluviral and Intanza
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified April 2012 - Exercise Intensity, Glycemic Control and Abdominal Fat in People With Type 2 Diabetes: A Pilot StudyCondition: Type 2 Diabetes Mellitus
Interventions: Behavioral: Traditional Intensity Exercise; Behavioral: High Intensity Interval Exercise
Sponsors: University of Alberta; University of Alberta; Alberta Diabetes Institute
Completed - verified January 2012 - Condition: Recurrent Breast Cancer
Intervention: Drug: Foretinib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Rectal Cancer
Intervention: Radiation: Radiation
Sponsors: Alberta Health Services; Alberta Health Services; IGAR Image guided adaptive radiotherapy
Recruiting - verified April 2012 - Condition: Anticoagulation
Interventions: Drug: warfarin; Drug: Warfarin
Sponsors: University of Alberta; University of Alberta
Recruiting - verified December 2011 - Conditions: Obesity; Obstructive Sleep Apnea
Intervention:
Sponsors: Katz, Sherri Lynne, M.D.; Katz, Sherri Lynne, M.D.; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Condition: Metastatic Sarcoma
Intervention: Drug: SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified April 2012 - Condition: Indeterminate Thyroid Nodules
Interventions: Procedure: Total Thyroidectomy + CLND; Procedure: Total thyroidectomy - CLND; Procedure: Hemi-thyroidectomy + CLND; Procedure: Hemi-thyroidectomy - CLND
Sponsors: University of Alberta; University of Alberta; Dalhousie University
Recruiting - verified July 2011 - Condition: Chronic Hepatitis C - Genotype 3
Intervention:
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified February 2010 - Condition: Pulmonary Hypertension (Idiopathic, Familial or Anorexigen-associated)
Interventions: Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium
Sponsors: University of Alberta; University of Alberta; Imperial College London
Enrolling by invitation - verified November 2011 - Condition: Acute Asthma
Interventions: Behavioral: Opinion Leader letter; Behavioral: Involvement of a care manager; Behavioral: Usual care
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified April 2012 - Condition: Prostate Cancer
Intervention: Drug: HDAC inhibitor SB939
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified March 2012 - Conditions: Migraine; Headache
Intervention: Drug: Normal saline
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2012 - Condition: Cardiac Surgery
Interventions: Procedure: Remote Ischemic Preconditioning; Procedure: Sham
Sponsors: McMaster University; Hamilton Health Sciences Corporation; Canadian Network and Centre for Trials Internationally
Active, not recruiting - verified May 2012 - Condition: Breast Cancer
Interventions: Behavioral: Physical Activity Resource Kit; Behavioral: Standard Materials
Sponsors: Athabasca University; Athabasca University; University of Alberta; University of Calgary; Alberta Health Services
Recruiting - verified January 2010 - Conditions: Chronic Obstructive Pulmonary Disease; Nocturnal Desaturation
Interventions: Device: Concentrator; Device: Sham concentrator
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Conditions: Oral Cancer; High-grade Precancer
Interventions: Procedure: Fluorescence visualization device; Procedure: Fluorescence visualization device
Sponsors: University of British Columbia; University of British Columbia; Terry Fox Research Institute; British Columbia Cancer Agency
Recruiting - verified December 2011 - Condition: Uveal Melanoma
Intervention: Drug: CP-675,206
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified September 2011 - Condition: Portal Hypertension
Intervention: Drug: Probiotic
Sponsors: University of Alberta; University of Alberta
Completed - verified January 2012 - Condition: Morbid Obesity
Intervention: Device: StomaphyX
Sponsors: University of Alberta; University of Alberta; Alberta Health Services
Enrolling by invitation - verified April 2012 - Condition: Gastroesophageal Reflux Disease (GERD)
Intervention: Device: EsophyX™ system with SerosaFuse fasteners
Sponsors: University of Alberta; University of Alberta; Alberta Health Services
Withdrawn - verified September 2011 - Conditions: Breast Cancer; Heart Failure
Intervention: Drug: perindopril OR bisoprolol OR placebo
Sponsors: Alberta Health Services; University of Alberta
Recruiting - verified April 2012 - Conditions: Renal Cell Carcinoma; Cardiotoxicity; Heart Failure; Hypertension
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified March 2012 - Condition: Brain Cancer
Intervention: Other: cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; Children's Healthcare of Atlanta; Dana-Farber Cancer Institute; M.D. Anderson Cancer Center; Phoenix Children's Hospital; Alberta Children's Hospital; University of Colorado, Denver; Seattle Children's Hospital; Johns Hopkins University; Children's Mercy Hospital-Kansas City, MO; MD Anderson Cancer Center Orlando at Arnold Palmer Hospital for Children
Recruiting - verified March 2012 - Condition: Lung Cancer
Interventions: Drug: PF-00299804; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Age-related Macular Degeneration
Intervention: Dietary Supplement: Ocean Nutrition MEG3 4020EE product
Sponsors: University of Alberta; Yves Sauve; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified November 2011 - Condition: Inflammatory Bowel Disease
Interventions: Device: Confocal endomicroscopy; Device: Confocal endomicroscopy
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Burns
Interventions: Dietary Supplement: Enteral Glutamine; Dietary Supplement: Placebo
Sponsors: Clinical Evaluation Research Unit at Kingston General Hospital; Daren K. Heyland; Canadian Institutes of Health Research (CIHR); American Burn Association
Recruiting - verified March 2012 - Conditions: Chronic Rhinosinusitis With Polyposis; Chronic Hyperplastic Sinusitis
Interventions: Drug: Tranexamic Acid; Drug: Normal Saline (placebo)
Sponsors: University of Alberta; University of Alberta
Completed - verified April 2012 - Condition: Acute Renal Failure
Interventions: Drug: Furosemide; Drug: Placebo
Sponsors: University of Alberta; University of Alberta; Grey Nuns Community Hospital, Edmonton, Canada; Austin Hospital, Melbourne Australia; Princess Alexandra Hospital, Brisbane, Australia
Recruiting - verified December 2011 - Condition: Intracerebral Hemorrhage
Intervention: Drug: labetalol/hydralazine/enalapril
Sponsors: University of Alberta; University of Alberta; Heart and Stroke Foundation of Canada; Alberta Heritage Foundation for Medical Research
Completed - verified February 2012 - Conditions: Lung Neoplasms; Cachexia
Interventions: Other: Blood draws; Biological: Oral administration of stable isotope (deuterium); Procedure: Metabolic rate testing
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified April 2012 - Conditions: Myocardial Infarction; Stroke; Renal Failure
Interventions: Drug: atorvastatin 80 mg per os daily; Drug: placebo
Sponsors: University of Alberta; University of Alberta
Completed - verified December 2011 - Condition: Kidney Transplant
Interventions: Biological: Zostavax (Live attenuated herpes zoster vaccine); Biological: Placebo vaccine
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Meningococcal C Disease
Intervention: Biological: Neisvac-C (Meningococcal C Conjugate Vaccine)
Sponsors: University of British Columbia; University of British Columbia; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Condition: Latent Tuberculosis Infection
Interventions: Drug: Isoniazid; Drug: Rifampin
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Conditions: Nausea and Vomiting; Pain; Sleep Disorders; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: methadone hydrochloride; Other: questionnaire administration; Procedure: management of therapy complications
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Terminated - verified July 2011 - Condition: Bone Scan
Intervention: Other: 18F-Sodium Fluoride (Na18F)
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Breast Cancer
Intervention: Radiation: Prophylactic Cranial Irradiation
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified August 2011 - Conditions: Ischemic Stroke; Transient Ischemic Attacks
Interventions: Drug: Antihypertensive agents and lipid lowering therapy; Other: Usual Care
Sponsors: University of Alberta; University of Alberta; Heart and Stroke Foundation; Alberta Heritage Foundation for Medical Research
Recruiting - verified December 2011 - Conditions: Pregnancy; Thrombophilia; Pregnancy Complications
Interventions: Drug: dalteparin sodium 5,000 IU prefilled syringes (antenatal); Drug: dalteparin sodium (after delivery - Control group)
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Conditions: Lung Neoplasm; Small Cell Carcinoma
Intervention: Radiation: Hypofractionated Chest Radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified September 2011 - Condition: Open Angle Glaucoma
Interventions: Procedure: Trabectome +/- Cataract Surgery; Procedure: Trabeculectomy with Mitomycin C +/- Cataract Surgery
Sponsors: University of Alberta; University of Alberta
Recruiting - verified April 2012 - Condition: Non-small Cell Lung Cancer
Intervention: Radiation: Stereotactic Radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Obesity
Interventions: Other: Nutrition counseling + portion control tool; Other: Nutrition counseling
Sponsors: University of Calgary; University of Calgary
Recruiting - verified October 2011 - Condition: Hypertension
Interventions: Other: Enhanced pharmacist care; Other: Usual Care
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Condition: Diabetes Mellitus
Interventions: Behavioral: High volume combined aerobic/resistance exercise; Behavioral: Low volume combined aerobic/resistance exercise; Behavioral: High volume combined A/R exercise, printouts, pedometers; Behavioral: Low volume combined A/R exercise, printouts, pedometers; Behavioral: Printed PA information, pedometers and step log group; Behavioral: Control
Sponsors: University of Calgary; University of Calgary
Active, not recruiting - verified August 2011 - Condition: Non-small Cell Lung Cancer
Intervention: Procedure: CT- simulation scan
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified August 2011 - Condition: Obesity
Intervention:
Sponsors: University of Alberta; University of Alberta; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Condition: Chronic Kidney Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Active, not recruiting - verified November 2011 - Conditions: Anxiety Disorder; Cognitive/Functional Effects; Colorectal Cancer; Depression; Fatigue; Psychosocial Effects of Cancer and Its Treatment; Sleep Disorders
Interventions: Behavioral: exercise intervention; Other: counseling intervention; Other: educational intervention; Other: laboratory biomarker analysis; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: fatigue assessment and management; Procedure: quality-of-life assessment
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Cystic Fibrosis
Interventions: Other: Positive Expiratory Pressure (PEP); Other: High Frequency Chest Wall Oscillation (HFCWO) using InCourage Vest System
Sponsors: University of British Columbia; University of British Columbia; Canadian Cystic Fibrosis Foundation
Active, not recruiting - verified April 2012 - Condition: Head and Neck Cancer
Interventions: Biological: panitumumab; Drug: cisplatin; Radiation: 3-dimensional conformal radiation therapy; Radiation: accelerated radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified November 2011 - Condition: Colonic Neoplasms
Interventions: Behavioral: Exercise Training; Other: Usual Care
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Glioma
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Conditions: Brain Cancer; Cancer; Solid Tumor; Lymphoma
Intervention: Biological: 18F-FLT
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified March 2012 - Conditions: Triage; Pediatrics
Intervention:
Sponsors: St. Justine's Hospital; St. Justine's Hospital; SickKids Foundation; Canadian Institutes of Health Research (CIHR)
Completed - verified July 2011 - Condition: Hematoma
Interventions: Drug: low molecular weight heparin or unfractionated heparin; Drug: Warfarin or coumadin
Sponsors: University of Ottawa Heart Institute; University of Ottawa Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified July 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: cediranib maleate; Drug: paclitaxel; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified March 2012 - Condition: Cytomegalovirus Infection
Intervention:
Sponsors: University of Alberta; University of Alberta
Completed - verified April 2012 - Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus; Genetic: gene expression analysis; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Type 1 Diabetes
Interventions: Drug: Pantoprazole; Drug: Sitagliptin
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified October 2011 - Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Procedure: Selective Neck Dissection Including Level IIB; Procedure: Selective Neck Dissection Excluding Level IIB
Sponsors: University of Alberta; Peter Dziegielewski
Enrolling by invitation - verified January 2012 - Conditions: Lung Neoplasm; Cell Hypoxia
Interventions: Other: 18F-FAZA; Other: 18F-Fluorodeoxyglucose (18F-FDG)
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Hypoxic Tumours
Intervention: Other: 18F-FAZA
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Breast Neoplasm
Interventions: Drug: 18F-FAZA PET scan; Drug: FluGlucoScan Injection (18F-FDB) PET scan
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified March 2012 - Condition: Prostate Cancer
Intervention: Procedure: 3T MR Spectroscopy
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Anal Canal Cancer
Intervention: Radiation: Tomotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Conditions: Lung Cancer; Tobacco Use Disorder
Interventions: Other: laboratory biomarker analysis; Other: screening questionnaire administration; Procedure: bronchoscopic and lung imaging studies; Procedure: computed tomography; Procedure: endoscopic biopsy; Procedure: quality-of-life assessment
Sponsors: British Columbia Cancer Agency; British Columbia Cancer Agency
Active, not recruiting - verified March 2012 - Condition: Ventricular Function, Left
Interventions: Procedure: Cardiac magnetic Resonance study; Procedure: Blood testing
Sponsors: University of Calgary; University of Calgary
Terminated - verified October 2011 - Condition: Schizophrenia
Intervention: Drug: L-Arginine
Sponsors: University of Alberta; University of Alberta; Capital Health, Canada
Active, not recruiting - verified January 2012 - Condition: Temporal Lobe Epilepsy
Intervention: Procedure: Hippocampal Electrical Stimulation
Sponsors: University of Calgary; University of Calgary; University of Western Ontario, Canada; University of Toronto; Dalhousie University; University of Alberta
Terminated - verified March 2012 - Condition: Low-Income Population
Interventions: Behavioral: Control Model (EXIST); Behavioral: Primary Health Care Model; Behavioral: Recreation Coordination Model (REC); Behavioral: Comprehensive Model (COMP)
Sponsors: University of Alberta; University of Alberta
Completed - verified November 2011 - Conditions: Testicular Cancer; Seminoma; Non-seminomatous
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified August 2011 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Condition: Liver Tumors
Intervention: Radiation: Stereotactic Body Radiation Therapy
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified August 2011 - Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Procedure: Radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Conditions: Burn; Hypertrophic Scar
Interventions: Drug: interferon alpha 2b; Drug: placebo
Sponsors: University of Alberta; University of Alberta
Not yet recruiting - verified November 2011 - Condition: Breast Cancer
Intervention: Other: Cardio-vascular MRI
Sponsors: University of Calgary; University of Calgary
Terminated - verified October 2011 - Condition: Prostate Cancer
Interventions: Procedure: 3T MR Imaging; Procedure: C-Choline PET Scanning; Procedure: Gene Rearrangement
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Other: multidisciplinary approach; Other: multifactorial approach - for enhanced care group; Other: reflects current patterns of care
Sponsors: University of Alberta; University of Alberta; Alberta Heritage Foundation for Medical Research
Recruiting - verified November 2011 - Condition: Transplant
Intervention:
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified April 2012 - Condition: Kidney Transplant
Intervention:
Sponsors: University of Alberta; University of Alberta
Completed - verified September 2011 - Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant RecipientsCondition: Transplant
Intervention: Biological: Human papillomavirus quadrivalent vaccine
Sponsors: University of Alberta; University of Alberta
Active, not recruiting - verified September 2011 - Condition: Critical Illness
Interventions: Procedure: Protocolized Sedation; Procedure: Protocolized sedation, with daily interruption
Sponsors: Mount Sinai Hospital, Canada; Mount Sinai Hospital, Canada; Canadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute
Active, not recruiting - verified September 2011 - Condition: Acute Kidney Injury
Interventions: Device: Continuous venvenous hemofiltration (CVVH); Device: Continuous venovenous hemodialysis (CVVHD)
Sponsors: St. Michael's Hospital, Toronto; St. Michael's Hospital, Toronto; University of Toronto
Completed - verified March 2012 - Conditions: Cardiac Surgery; Cardiopulmonary Bypass
Interventions: Drug: Sodium Bicarbonate; Drug: Sodium Chloride
Sponsors: Austin Health; Austin Health
Recruiting - verified November 2009 - Conditions: Clinically Isolated Syndromes; Early Single Relapse of Multiple Sclerosis
Interventions: Drug: Apo-Minocycline; Drug: Placebo Comparator
Sponsors: University of Calgary; Dr. Luanne Metz; Multiple Sclerosis Society of Canada
Recruiting - verified March 2012 - Condition: Total Knee Arthroplasty
Interventions: Procedure: Femoral Block; Other: Usual Care
Sponsors: Edmonton Civic Employees Research Fund; Edmonton Civic Employees Research Fund
Completed - verified February 2008 - Condition: Head and Neck Cancer
Intervention: Other: PET/CT
Sponsors: University of Calgary; University of Calgary; Tom Baker Cancer Centre
Completed - verified April 2008 - Conditions: Spinal Cord Injury; Quadriplegia; Tetraplegia
Interventions: Behavioral: FES-assisted In-home telerehabilitation of hand function; Behavioral: Exercise training
Sponsors: University of Alberta; University of Alberta; International Spinal Research Trust; Alberta Heritage Foundation for Medical Research
Active, not recruiting - verified November 2011 - Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Drug: brivanib alaninate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Lung Cancer
Intervention: Other: CT scan of the chest under deep inspiration breath hold
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified August 2011 - Condition: Extensive Stage Small Cel Lung Cancer
Intervention: Radiation: thoracic radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified April 2012 - Condition: Respiratory Insufficiency of Prematurity
Intervention: Other: Titration of oxygen therapy
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention:
Sponsors: University of Alberta; University of Alberta
Completed - verified October 2011 - Condition: Iron Deficiency Anemia
Interventions: Device: Diagnostic Test - Given Imaging Pillcam; Other: Diagnostics
Sponsors: University of Calgary; University of Calgary; Alberta Heritage Foundation for Medical Research; Calgary Health Region
Recruiting - verified December 2011 - Conditions: Deglutition Disorders; Dysphagia; Stroke
Intervention: Other: TOR-BSST© Refresher Training
Sponsors: University Health Network, Toronto; University Health Network, Toronto; Ontario Ministry of Health and Long Term Care
Completed - verified January 2012 - Condition: Endothelial Function
Intervention: Other: ischemia reperfusion
Sponsors: University of Calgary; University of Calgary
Completed - verified October 2011 - Conditions: Vascular Diseases; Myocardial Ischemia
Interventions: Drug: adenosine; Other: modified end-tidal forcing system; Other: arm cuff occlusion; Device: Breathing gas; Device: Blood pressure cuff
Sponsors: University of Calgary; University of Calgary
Completed - verified October 2011 - Condition: Neoplasms
Intervention: Drug: Dichloroacetate
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified January 2012 - Conditions: Infarction; Ischemia; Magnetic Resonance Imaging
Intervention: Procedure: Cardiac magnetic Resonance study
Sponsors: University of Calgary; University of Calgary
Completed - verified October 2011 - Conditions: Genetic Markers; Cardiac Toxicity; Breast and Skin Motion
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified September 2011 - Conditions: Type 1 Diabetes; Hypoglycemia
Intervention: Device: Use of glucose sensor (Paradigm Guardian)
Sponsors: University of Alberta; University of Alberta
Completed - verified September 2011 - Conditions: Type 1 Diabetes; Pregnancy
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified September 2011 - Conditions: Remote Ischemic Preconditioning; Myocardial Protection
Intervention: Device: Blood Pressure Cuff
Sponsors: University of Alberta; University of Alberta
Completed - verified February 2012 - Condition: Breast Cancer
Intervention: Procedure: Blood Test
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified January 2012 - Condition: Squamous Cell Cancer
Intervention: Other: PET-CT
Sponsors: Alberta Health Services; Alberta Health Services; Calgary Health Region
Completed - verified August 2011 - Condition: Prostate Cancer
Intervention: Procedure: Blood test
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified April 2012 - Condition: Type 1 Diabetes Mellitus
Intervention: Other: Virtual visit
Sponsors: University of Calgary; University of Calgary; Canadian Diabetes Association
Completed - verified October 2011 - Condition: Melanoma (Skin)
Interventions: Biological: recombinant human interleukin-21; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Condition: Head and Neck Cancer
Interventions: Procedure: Salivary gland transfer; Procedure: Helical Tomotherapy treatment
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis
Intervention: Behavioral: Exercise
Sponsors: University of Alberta; University of Alberta; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2012 - Conditions: Prematurity; Respiratory Distress Syndrome, Newborn
Interventions: Device: CPAP; Device: Mechanical ventilation
Sponsors: Children's & Women's Health Centre of British Columbia; Children's & Women's Health Centre of British Columbia; Child and Family Research Institute
Terminated - verified February 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Genetic: DNA methylation analysis; Procedure: quality-of-life assessment; Radiation: Radiation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC; Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified March 2012 - Condition: Colonic Neoplasms
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified April 2012 - Conditions: Lung Neoplasm; Small Cell Carcinoma
Intervention: Procedure: hypofractionated external beam
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Conditions: Lung Neoplasm; Small Cell Carcinoma; Bladder Carcinoma
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Mesothelioma
Intervention: Procedure: Tomotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified April 2012 - Condition: the Efficacy and Safety of Off-pump CABG
Interventions: Procedure: Coronary Artery Bypass Graft with the use of CPB; Procedure: Coronary Artery Bypass Graft without the use of CPB
Sponsors: Population Health Research Institute; Population Health Research Institute; McMaster University; University of Oxford; Instituto Dante Pazzanese de Cardiologia; ECLA Clinical Research Organization,; Fu Wai Hospital, Beijing, China; Facultad de Medicina, Universidad de La Frontera, Temuco, Chile; Fundación Cardiovascular de Colombia; Charles University, Czech Republic; Hopital Jean Minjoz; Centre for Chronic Disease Control, India; S. C. di Cardiochirurgia, Ospedale Santa Croce a Carle, Cuneo, Italy; Medical University of Gdansk; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Ankara University; Hotel Dieu Hospital; Centre hospitalier de l'Université de Montréal (CHUM); SAL Hospital, Ahmedabad, India
Recruiting - verified July 2011 - Condition: Advanced Cancer
Intervention: Behavioral: Home-based physical activity program
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified January 2012 - Condition: Cystic Fibrosis
Interventions: Drug: azithromycin 250 mg tablets; Drug: placebo tablets
Sponsors: CF Therapeutics Development Network Coordinating Center; CF Therapeutics Development Network Coordinating Center; Cystic Fibrosis Foundation
Completed - verified February 2012 - Condition: Neoplasms
Intervention:
Sponsors: University of Alberta; Karin Olson
Completed - verified November 2011 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: bortezomib; Drug: cyclophosphamide; Drug: prednisone; Drug: vincristine sulfate
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Condition: Pancreatic Cancer
Intervention: Procedure: Positron-Emission Tomography (PET) 18F-FLT
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified March 2012 - Condition: Diabetes
Intervention: Behavioral: Resistance Exercise
Sponsors: Ottawa Hospital Research Institute; Ottawa Hospital Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified May 2012 - Condition: Breast Neoplasms
Interventions: Behavioral: Mindfulness Meditation-Based Stress Reduction; Behavioral: Supportive-Expressive Group Therapy
Sponsors: Alberta Health Services; Canadian Breast Cancer Research Alliance; British Columbia Cancer Agency
Active, not recruiting - verified August 2011 - Condition: Supraventricular Tachycardia in Infants
Intervention: Drug: digoxin and propranolol
Sponsors: University of British Columbia; University of British Columbia; The Hospital for Sick Children; University of Utah
Completed - verified October 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus; Drug: temozolomide; Genetic: microarray analysis; Other: immunohistochemistry staining method
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Conditions: Lung Neoplasms; Positron Emission Tomography
Intervention: Procedure: PET/CT scan for RT planning
Sponsors: Alberta Health Services; Alberta Health Services; Calgary Health Region
Recruiting - verified August 2011 - Condition: Traumatic Brain Injury
Interventions: Drug: Darbeopoetin; Drug: Normal Saline (Placebo)
Sponsors: Royal Alexandra Hospital; Royal Alexandra Hospital; University of Alberta
Completed - verified March 2012 - Condition: Lymphoma
Interventions: Drug: bortezomib; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified June 2011 - Condition: Head and Neck Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Head and Neck Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Metastatic Breast Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified December 2011 - Conditions: Lung Neoplasms; Lung Cancer
Intervention: Procedure: Fractionated Stereotactic Radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified January 2012 - Conditions: Cancer; Pain
Intervention: Drug: Sublingual Methadone
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified January 2012 - Condition: Lung Cancer
Intervention: Radiation: 3-dimensional conformal radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Glioma
Interventions: Procedure: MRS Imaging; Procedure: PET Scanning; Procedure: Diffusion Tensor Imaging
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Conditions: Renal Cell Carcinoma; Neuroendocrine Tumours
Intervention: Drug: 18F-FAZA PET Imaging
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified March 2012 - Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: University of Calgary; University of Calgary; Heart and Stroke Foundation of Canada
Completed - verified April 2012 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified April 2012 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified January 2012 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Prostate Cancer
Intervention: Device: Magnetic Resonance Spectroscopy (3Tesla)
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Healthy
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Condition: Rectal Cancer
Intervention: Procedure: surgery
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada
Active, not recruiting - verified March 2010 - Condition: -Breast Neoplasms
Intervention: Procedure: MRI
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified December 2011 - Condition: Breast Cancer
Interventions: Radiation: 3D-CRT APBI; Radiation: WBI
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance
Active, not recruiting - verified July 2011 - Condition: Anaplastic Thyroid Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified July 2011 - Conditions: Prostatic Neoplasms; Neoplasm Metastasis; Palliative Care
Intervention: Behavioral: Exercise training
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Metastatic Colorectal Cancer
Interventions: Drug: Glutamine; Other: Placebo
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified January 2012 - Conditions: Glioblastoma; Glioma
Intervention: Procedure: Functional MRI imaging and tomotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified October 2011 - Condition: Breast Cancer
Intervention: Behavioral: Physical exercise
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified April 2012 - Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Pentoxifylline
Sponsors: Cooperative International Neuromuscular Research Group; Cooperative International Neuromuscular Research Group
Completed - verified October 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: cediranib maleate; Drug: paclitaxel; Other: placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified August 2011 - Condition: Breast Cancer
Interventions: Drug: letrozole; Other: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Condition: Type 1 Diabetes
Interventions: Drug: alemtuzumab; Procedure: islet transplant
Sponsors: University of Alberta; University of Alberta; Juvenile Diabetes Research Foundation
Active, not recruiting - verified October 2011 - Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council, Australia
Active, not recruiting - verified March 2012 - Condition: Head and Neck Cancer
Interventions: Procedure: radiation treatment and surgery; Procedure: radiation alone
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified October 2011 - Condition: Latent Tuberculosis Infection
Intervention: Drug: Isoniazide (drug), Rifampin (drug)
Sponsors: McGill University; McGill University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Coronary Artery Disease
Intervention: Procedure: Radial Artery and Saphenous Vein Grafts Randomized to either right coronary or left circumflex coronary artery territories
Sponsors: Sunnybrook Health Sciences Centre; Sunnybrook Health Sciences Centre; Canadian Institutes of Health Research (CIHR)
Completed - verified November 2011 - Condition: Cancer, Carcinoma
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Bone Neoplasms
Intervention: Procedure: Helical tomotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Fatigue
Intervention: Behavioral: exercise
Sponsors: Alberta Health Services; Alberta Health Services; Alberta Cancer Foundation
Completed - verified August 2011 - Condition: Hematologic Malignancy
Intervention: Drug: intravenous busulfan
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified September 2011 - Condition: - Breast Cancer
Intervention: Procedure: Aloe barbadensis topical application in a moisturizing cream vehicle.
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Low Grade Lymphoma
Intervention: Procedure: stem cell source
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified August 2011 - Condition: Head and Neck Cancer
Intervention: Procedure: Intensity-Modulated Radiation Therapy
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified March 2012 - Condition: Glioma
Intervention: Device: imaging and angiogenic profiles
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified April 2012 - Condition: Osteoporosis
Interventions: Procedure: bone densitometry (DEXA); Drug: alendronate or risedronate
Sponsors: University of Alberta; University of Alberta; Alberta Heritage Foundation for Medical Research
Completed - verified December 2011 - Conditions: Lung Cancer; Colorectal Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified April 2012 - Condition: Breast Cancer
Intervention: Drug: FEC 100
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified October 2011 - Condition: Colon Cancer
Intervention: Drug: 5FU/LV
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified December 2011 - Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung CancerCondition: Carcinoma, Non-Small-Cell Lung
Intervention: Procedure: Tomotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Brain Neoplasms
Intervention: Procedure: Tomotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified April 2012 - Condition: Prostate Cancer
Intervention: Procedure: Hypofractionated radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified October 2011 - Condition: Prostate Cancer
Intervention: Procedure: Permanent prostate implant
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified March 2012 - Condition: Carcinoma, Small Cell
Intervention: Procedure: External beam radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified October 2011 - Condition: Prostate Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Prostate Cancer
Intervention: Procedure: Tomotherapy
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified April 2012 - Condition: Cervix Cancer
Intervention: Procedure: CT and MR fusion
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Prostatic Neoplasm
Intervention: Procedure: Magnetic Resonance Spectroscopy Imaging
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Colon Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified April 2012 - Condition: Prostate Cancer
Intervention: Procedure: radiotherapy
Sponsors: Alberta Health Services; Alberta Health Services; Calgary Health Region
Completed - verified January 2012 - Conditions: Cancer; Hypercalcemia; Pain
Intervention: Drug: Zoledronic acid (Zometa)
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified August 2011 - Condition: Malignant Glioma
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Recruiting - verified May 2012 - Condition: Malignant Glioma
Intervention: Procedure: 3T MRI Scanning
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified May 2012 - Conditions: Cancer; Pain
Intervention: Drug: morphine
Sponsors: Alberta Health Services; Alberta Health Services; Tom Baker Cancer Centre
Completed - verified August 2011 - Conditions: Nausea; Neoplasms
Interventions: Drug: Olanzapine; Drug: Haldol
Sponsors: Alberta Health Services; Alberta Health Services; Canadian Institutes of Health Research (CIHR)
Terminated - verified January 2012 - Conditions: Prostate Cancer; Osteoporosis
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Cervix Neoplasm
Intervention: Device: Tomotherapy Treatment Planning
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified December 2011 - Condition: Cervix Cancer
Intervention: Procedure: Megavoltage CT scan
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified April 2012 - Condition: Sarcoma
Intervention: Procedure: Positron Emission Tomography
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified March 2012 - Condition: Lung Neoplasms
Intervention: Procedure: Positron Emission Tomography (PET) scan Imaging
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Breast Neoplasms
Intervention: Procedure: Positron Emission Tomography Imaging
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified March 2012 - Conditions: Brain Neoplasms; Lung Neoplasms; Thyroid Neoplasms; Colorectal Neoplasms; Lymphoma
Intervention: Procedure: Positron Emission Tomography (PET) scan
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Conditions: Sarcoma; Multiple Myeloma; Testicular Neoplasms; Ovarian Neoplasms; Kidney Neoplasms
Intervention: Procedure: Positron Emission Tomography
Sponsors: Alberta Health Services; Alberta Health Services
Completed - verified March 2012 - Condition: Prostate Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified December 2011 - Conditions: Breast Cancer; Glioma; Prostate Cancer; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell-Lung; Head and Neck Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified March 2012 - Condition: Prostate Cancer
Intervention:
Sponsors: Alberta Health Services; Alberta Health Services
Terminated - verified April 2012 - Conditions: Rectal Cancer; Neoplasm Metastasis
Interventions: Drug: Capecitabine; Procedure: Pelvic radiation
Sponsors: Alberta Health Services; Alberta Health Services
Active, not recruiting - verified August 2011 - Condition: Syncope, Vasovagal, Neurally-Mediated
Intervention: Drug: fludrocortisone acetate
Sponsors: University of Calgary; University of Calgary; Canadian Institutes of Health Research (CIHR)
Completed - verified April 2012 - Condition: Bipolar Disorder
Interventions: Drug: MCN36 (nutritional supplement); Drug: Placebo
Sponsors: University of Calgary; University of Calgary; Alberta Innovation and Science
Terminated - verified March 2009 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: cisplatin; Drug: cytarabine; Drug: dexamethasone; Drug: gemcitabine hydrochloride; Other: clinical observation
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: CHOP regimen
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Active, not recruiting - verified May 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Drug: topotecan hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified August 2011 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Biological: epoetin alfa; Biological: filgrastim; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: paclitaxel
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; North Central Cancer Treatment Group; Southwest Oncology Group
Active, not recruiting - verified May 2012 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: prednisone; Drug: thalidomide
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Interventions: Drug: carboplatin; Drug: gemcitabine hydrochloride
Sponsors: National Cancer Institute (NCI); AGO Study Group; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified June 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified September 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: paclitaxel; Drug: rebimastat
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified August 2011 - Condition: Sarcoma
Intervention: Drug: alvocidib
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified April 2012 - Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone; Drug: melphalan; Drug: prednisone
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate; Drug: dacarbazine; Drug: doxorubicin hydrochloride; Drug: vinblastine; Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group
Completed - verified January 2012 - Condition: Lung Cancer
Interventions: Drug: marimastat; Drug: Placebo
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified January 2012 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified March 2012
 |
Join Clinical Trials by University in Alberta |
